BACKGROUND & OBJECTIVE: CpG island methylator phenotype (CIMP) is cancer-specific and involves in the promoter hypermethylation of multiple genes. It is correlated to the genesis or prognosis of various tumors, but it has rarely been reported in hepatocellular carcinoma (HCC). OPCML (opioid-binding protein/cell adhesion molecule-like) gene has been studied mainly in epithelial ovarian cancer, and is thought to be a candidate tumor suppressor gene in epithelial ovarian cancer. This study was to explore the correlations of CIMP and OPCML gene expression to the carcinogenesis of HCC. METHODS: The methylation status of OPCML, p15, SOCS-1, GST-p, RAR-b, p16, p73, p14, MGMT, hMLH1 in 50 specimens of HCC and pericancer tissues was detected using methylation-specific polymerase chain reaction (MSP). RESULTS: The hypermethylation rates of genes were higher in HCC than in pericancer tissues [OPCML (70.0% vs. 64.6%), p15 (58.0% vs. 50.0%), SOCS-1 (78.0% vs. 50.0%), GST-p (56.0% vs. 27.1%), RAR-b (30.0% vs. 6.3%), p16 (26.0% vs. 14.6%), p73 (16.0% vs. 0%), p14 (36.0 vs. 27.1%), MGMT (16.0% vs. 10.4%), and hMLH1 (18.0% vs. 4.2%)]. The methylation rates of SOCS-1, GST-p, RAR-b, p16 and p73 were significantly higher in HCC than in adjacent non-neoplastic tissues (P<0.05). The recurrence occurred earlier in CIMP-positive group (> or =3 methylated genes) than in CIMP-negative group (<3 methylated genes)(P<0.05). The 1-year disease-freely survival rate was significantly lower in CIMP-positive group than in CIMP-negative group (18.2% vs. 75.0%, P<0.05). CONCLUSIONS: CIMP exists in HCC, and may be a prognostic factor of HCC. Promoter methylation of OPCML gene may play an important role in hepatocarcinogenesis.
BACKGROUND & OBJECTIVE: CpG island methylator phenotype (CIMP) is cancer-specific and involves in the promoter hypermethylation of multiple genes. It is correlated to the genesis or prognosis of various tumors, but it has rarely been reported in hepatocellular carcinoma (HCC). OPCML (opioid-binding protein/cell adhesion molecule-like) gene has been studied mainly in epithelial ovarian cancer, and is thought to be a candidate tumor suppressor gene in epithelial ovarian cancer. This study was to explore the correlations of CIMP and OPCML gene expression to the carcinogenesis of HCC. METHODS: The methylation status of OPCML, p15, SOCS-1, GST-p, RAR-b, p16, p73, p14, MGMT, hMLH1 in 50 specimens of HCC and pericancer tissues was detected using methylation-specific polymerase chain reaction (MSP). RESULTS: The hypermethylation rates of genes were higher in HCC than in pericancer tissues [OPCML (70.0% vs. 64.6%), p15 (58.0% vs. 50.0%), SOCS-1 (78.0% vs. 50.0%), GST-p (56.0% vs. 27.1%), RAR-b (30.0% vs. 6.3%), p16 (26.0% vs. 14.6%), p73 (16.0% vs. 0%), p14 (36.0 vs. 27.1%), MGMT (16.0% vs. 10.4%), and hMLH1 (18.0% vs. 4.2%)]. The methylation rates of SOCS-1, GST-p, RAR-b, p16 and p73 were significantly higher in HCC than in adjacent non-neoplastic tissues (P<0.05). The recurrence occurred earlier in CIMP-positive group (> or =3 methylated genes) than in CIMP-negative group (<3 methylated genes)(P<0.05). The 1-year disease-freely survival rate was significantly lower in CIMP-positive group than in CIMP-negative group (18.2% vs. 75.0%, P<0.05). CONCLUSIONS:CIMP exists in HCC, and may be a prognostic factor of HCC. Promoter methylation of OPCML gene may play an important role in hepatocarcinogenesis.
Authors: R Sriraksa; C Zeller; M A El-Bahrawy; W Dai; J Daduang; P Jearanaikoon; S Chau-In; R Brown; T Limpaiboon Journal: Br J Cancer Date: 2011-03-29 Impact factor: 7.640
Authors: Caroline D E Margetts; Mark Morris; Dewi Astuti; Dean C Gentle; Alberto Cascon; Fiona E McRonald; Daniel Catchpoole; Mercedes Robledo; Hartmut P H Neumann; Farida Latif; Eamonn R Maher Journal: Endocr Relat Cancer Date: 2008-05-22 Impact factor: 5.678